Vontobel Holding Ltd. bought a new position in shares of Chemed Co. (NYSE:CHE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,045 shares of the company's stock, valued at approximately $1,083,000.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Chemed during the 4th quarter worth $2,540,000. Van ECK Associates Corp raised its holdings in Chemed by 30.4% in the fourth quarter. Van ECK Associates Corp now owns 15,141 shares of the company's stock worth $8,022,000 after purchasing an additional 3,531 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Chemed by 9.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,052 shares of the company's stock valued at $24,314,000 after buying an additional 3,785 shares during the last quarter. Schwartz Investment Counsel Inc. boosted its holdings in shares of Chemed by 1.0% in the 4th quarter. Schwartz Investment Counsel Inc. now owns 119,163 shares of the company's stock valued at $63,133,000 after buying an additional 1,173 shares in the last quarter. Finally, Portfolio Design Labs LLC purchased a new position in shares of Chemed in the 4th quarter worth approximately $324,000. Institutional investors own 95.85% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts recently commented on CHE shares. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.
View Our Latest Stock Report on Chemed
Chemed Price Performance
NYSE CHE traded down $5.35 during trading on Friday, hitting $544.75. The company's stock had a trading volume of 126,310 shares, compared to its average volume of 89,824. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The company has a market cap of $8.20 billion, a PE ratio of 27.53, a P/E/G ratio of 2.17 and a beta of 0.48. The business's 50 day simple moving average is $542.64 and its 200-day simple moving average is $563.96.
Chemed Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Monday, February 24th. Chemed's dividend payout ratio (DPR) is presently 10.11%.
Insiders Place Their Bets
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares of the company's stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Brian C. Judkins purchased 145 shares of the business's stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by insiders.
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.